Bluejay Investor Presentation Deck
SymphonyTM System Commercial Advantages¹ v. Central Lab Analyzer Systems for IL-6
●●●
Near Patient
Test System Size
Sample Type
Advantages
Separate Sample Processing Step
Total Turnaround Time
Requires Dedicated Personnel*
System/Infrastructure Cost
NPV2 for IL-6 Assay
*(Phlebotomist/MedTech)
bluejay
DIAGNOSTICS
Bluejay Symphony™
Near Patient
Desktop
Whole Blood
No
~20 minutes
No
$
98%
Source: 1. Bluejay Diagnostics market research. 2. NPV = Negative Predictive Value. 3. Bluejay/Industry information, pending
the location of the testing lab. 4. from FDA Emergency Use Authorization company filings
The SymphonyTM System and SymphonyTM Cartridge have not been cleared or approved by the U.S. FDA
Beckman, Siemens, Roche
Central Lab
Very Large
Serum/Plasma
Yes
4-48hr³
Yes
$$$
78.6-92.9%4
Copyright ©2023 Bluejay Diagnostics, Inc. All rights reserved in all slides | November 2023
14View entire presentation